Pharmafile Logo

New analysis shows emergency hospital admissions for people with Multiple Sclerosis continue to rise

April 26, 2017 | Emergency care, Multiple Sclerosis 

Updated data published by Wilmington Healthcare and the MS Trust highlights need for more preventative care for MS patients

Emergency hospital admissions for people with Multiple Sclerosis (MS) are on the rise and costing the NHS millions; yet many of them could be avoided, according to a new summary of data by healthcare intelligence provider Wilmington Healthcare and the charity, the Multiple Sclerosis (MS) Trust.  

The information, which updates the authors’ previous analysis of English Hospital Episode Statistics (HES) from 2013/14, shows that emergency hospital admissions for people with MS in England increased by 12.7 percent over the two years to 2015/16.
 

According to the latest HES data, there were 26,679 emergency hospital admissions for people with MS in England in 2015/16, compared to 23,665 in 2013/14, and this cost the NHS a total of £46m.  

However, a large proportion of this emergency care was for problems which could have been avoided with proactive, preventative care and earlier diagnosis and intervention in the community.
 

For example, the report found that urinary tract infections accounted for 14 percent of emergency admissions for MS in 2015/16 and they cost £2,639 per patient; while respiratory issues cost the NHS a total of £5.4m.   Overall, admissions for bladder and bowel related issues for people with MS cost £10.4m in 2015/16.
 

The report found that nearly one in five of the 89,030 people living with MS in England were admitted to hospital as an emergency in 2015/16.  The average cost per admission was £1,733 and the average length of stay was 8.2 days.
 

Sue Thomas, CEO of the Commissioning Excellence Directorate for Wilmington Healthcare, said: “Our latest report shows that the problems we highlighted in our original 2013/14 analysis have increased in the past couple of years. A growing number of patients with MS are being admitted to hospital for emergency care; yet many of these admissions could have been avoided with earlier intervention.  

“Preventative care strategies for people with MS must be reviewed in order to tackle problems, such as respiratory and urinary tract infections, at an early stage to try to avert the need for emergency care. This would not only be of huge benefit to patients, it would also reduce pressure on struggling A&E departments.”  

Pam Macfarlane, Chief Executive of the MS Trust, which provides information for people with MS and supports MS specialist services, said: “It is disappointing to see that avoidable emergency hospital admissions for people with MS have continued to rise in 2015/16.
 

“Last November, the MS Trust brought together partners from across the MS sector to publish the MS Forward View consensus. This showed that people with MS need a flexible blend of care, comprising disease modification and also proactive symptom management and neurorehabilitation, delivered by multidisciplinary teams. This is one reason why we are now funding additional MS nurses in areas of the UK where services are the most overstretched. Only with the right specialist and community based support will we reduce the need for emergency hospital care for people with MS.”  


                                                                        Ends

This content was provided by Wilmington Healthcare

Company Details

 Latest Content from  Wilmington Healthcare 

Wilmington Healthcare makes new senior appointment

Healthcare intelligence provider Wilmington Healthcare, which incorporates Binley’s, NHiS, Wellards and HSJ, has promoted a longstanding employee, Shelley Jessop, to the role of Account Director.Shelley who has worked for Wilmington...

Wilmington Healthcare appoints new Account Director

Healthcare intelligence provider Wilmington Healthcare, which incorporates Binley’s, NHiS, Wellards and HSJ, has strengthened its salesforce with the appointment of Gareth Thurston as Account Director.

What will the NHS’s Capped Expenditure Process (CEP) mean for pharma?

Paul Midgley, Director of NHS Insight at Wilmington Healthcare, explains how pharma should tailor its approach

How will the NHS’s new medicines savings drive affect pharma?

Steve How and Sue Thomas, of Wilmington Healthcare, explore how pharma should engage with CCGs on prescribing saving targets

Launch of the HSJ Partnership Awards: a programme for inspirational organisations helping to transform the NHS

New Awards will recognise the many private sector organisations who partner with the NHS to deliver improved patient outcomes and cost-effective care

How can pharma help the NHS capitalise on its data?

Sue Thomas, Paul Midgley and Steve How, of Wilmington Healthcare, explain how pharma can work with the NHS to transform services

How can pharma engage with Accountable Care Systems?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, explain how pharma can add value across care pathways

New analysis shows emergency hospital admissions for people with Multiple Sclerosis continue to rise

Updated data published by Wilmington Healthcare and the MS Trust highlights need for more preventative care for MS patients

How will capitated budgets affect NHS spending?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess the implications of a single budget covering all the physical, mental and social care needs of patients in an STP

Wilmington Healthcare launches new, integrated, digital channel to help pharma engage with the NHS

Healthcare intelligence provider Wilmington Healthcare has integrated its tools and resources online to help pharma navigate changes within the NHS, following the official launch of Sustainability and Transformation Plans (STPs)....